Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity

Details for Australian Patent Application No. 2002217160 (hide)

Owner SWITCH BIOTECH AKTIENGESELLSCHAFT LUDWIG - MAXIMILIANS - UNIVERSITAT

Inventors Goppelt, Andreas; Kogel, Heidi; Alzheimer, Christian

Agent Watermark

Pub. Number AU-A-2002217160

PCT Pub. Number WO2002/053171

Priority 60/277,453 20.03.01 US; 100 65 475.4 28.12.00 DE

Filing date 27 December 2001

Wipo publication date 16 July 2002

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002217160

22 January 2004 Amendment Made

  The nature of the amendment is: Add the co-applicant/patentee Christian Alzheimer.

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002217161-REGULATION OF HUMAN PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE

2002217159-Piperazinylcarbonyliquinolines and - isoquinolines